We would love to hear your thoughts about our site and services, please take our survey here.
Hello,
Just dropped back in… wow what a discussion today! So many “helpful” people turning up to say how they have sold. Would you really do that? If you were genuinely selling wouldn't you just sell and go invest somewhere else, rather than fight with genuine holders to shout about your “concerns”? This behaviour becomes even more peculiar on a day the price gets bashed and volume is high.
Bash the price, disrupt the board, II’s load up, they’re laughing. So who is it you are working for polar or polygon? Let’s watch out for the TR1 to see…
All GENUINE holders, a valiant attempt to fend off the attack. We have taken our positions here, soon we will be rewarded for our quiet patience. So close now!
GLA
Ox
Morning!
Welldone everyone for holding this far. Today is going to be an awesome day.
It’s also nice timing that in the next 7 working days, the EU will announce the drugs on their “big 10” to get additional support - rolling reviews, regulatory approval across EU, manufacturing support and joint procurement.
The market are not expecting that.
Here’s the link or Google “EU covid therapeutics strategy” to read more.
https://www.insideeulifesciences.com/2021/05/10/european-commission-outlines-strategy-on-covid-19-therapeutics/
Enjoy the day!
Ox.
Morning,
The fundamental point is the proof that Synairgen are definitely involved with the EU therapeutics strategy.
So you would expect that they have applied for support as one of the “big ten”. Then the big question is - is SNG001 one of the 10 most promising treatments in the world? Will they be selected in October?
If so, they could get massive support to scale up rapidly, get EUA across the EU countries and joint procurement.
If anyone missed the EU covid therapeutics strategy, here’s what it covers:
“It covers the full lifecycle of medicines from research, development, selection of promising candidates, fast regulatory approval, manufacturing and deployment to final use. It will also coordinate, scale-up and ensure that the EU acts together in ensuring access to therapeutics via joint procurements.”
They are aiming for regulatory approval across the EU and manufacturing support. 5 drugs were selected in July (mostly Mabs) and 5 more are due to be announced in October. Synairgen must have a high chance here and it would be game changing.
Here’s the report link:
https://clustercollaboration.eu/sites/default/files/event_calendar/Proceedings%20Report%20-%20European%20Matchmaking%20event%20-%20Development%20and%20production%20of%20COVID-19%20therapeutics.pdf
Hi,
Ive not posted for a while, but I have some good news to share.
Here’s proof that Synairgen were at the EU covid therapeutics matchmaking event in July. Remember this event was part of the EU strategy to accelerate Covid therapeutics?
Synairgen is definitely involved.
See detailed event report below, and list of participants at the end of the report.
Plus an “anonymous” testimonial:
“After the presentation of the experts on Monday 12 July morning, we noted a great synergy between the recommendations and requests made in terms of treatment guidelines (presentation by Prof Roche) and what we are developing at our company.
If the results are positive, which we have no doubt they will be, we will have to consider an accelerated procedure for the registration of the product and the devices. We now know the contact persons to move in this direction.”
Anyone else think that a Covid therapeutics with devices sounds like Synairgen?
Oh dear, it’s not going well today is it dumbpunter.
Scaremongering only works when there’s not well informed posters to correct you.
At least we can spot when dumbass and friends stop bashing this share, alongside the algo trading, the price will bounce back. I am wonderinrg why today though dumb? Is it to build on the legitimate drop as some directors increased their holding through share options? Just opportunist? Or are you expecting something next week and picking up some shares today ahead of news? I find your world fascinating. I shall watch the next couple of weeks and see if in retrospect we understand your bashing today of all days.
Bighohnnywin- thanks for a chuckle this morning.
Anyone that starts with there’s never a good reason for directors to sell - is clearly incorrect. They covered it to pay the tax bill and there’s a world of other reasons that human being may sell their own share options before they expire
Secondly corporation tax is noting to do with exercise of personal share options. Google tax on share options.
Sorry to hear you have sold out on a misunderstanding but if that’s true, what are you still doing here. Take your cash and jog on. Good luck.
I’m really enjoying seeing Dumb and the professional derampers back today in tag team. Love when they feel they have to bother to bash this share price down. Hold tight all genuine investors, grab the popcorn and let’s see what other pearls these guys come up with :-)
Seaboy thank you for the amazing work you do.
It’s insightful and sad to hear how bad things are in hospital. I’ve no idea how all medics have kept going through such a long, painful slog. I hope the SNG armada (!) arrives soon and make this like any other illness that you can treat effectively.
I think Molnupiravir is a short term threat to sng share price (maybe a vaccine drop). We all know sng is a much better solution, but the pills may find their place for early infection especially with political backing, PR, cheaper price, convenience and easy supply. Medium term SNG will shine through and sell as much as they can manufacture, leading to licence or TO. I’m still fully invested here, just bracing for a few short term drops.
Like most people here, I’m invested for financial reasons but also because I believe in the difference this treatment will make. We know it’s safe, we know it works ;-)
Good luck all.
Graham, how can you possibly know SNG001 won’t help long covid sufferers?
WedME who many of us respected, posted that it would make medical sense that SNG001 as the orchestra of the immune system, could help regulate the dysfunctional response left by long covid. Bring it all back into alignment and stop the body attacking itself through an autoimmune condition. It seems to make sense. The truth is nobody knows until they hold a trial. Well maybe Sir Holgate knows.
Genki, hope your wife recovers soon.
Here’s the link to the website.
I recommend watching the main webinar.
(Don’t bother with the technical one, it’s irrelevant)
https://development-production-covid19.b2match.io/home
Let me try to be a bit more articulate than that rush post last night!
The EU therapeutics strategy has organised a manufacturing May banking event. SNG would qualify as an “immunomodulator”.
The event brings together different elements of the supply chain and purchasers in a “speed dating” format.
The EU said they will
Invest €19m in a flexible supply chain to support rapid production of therapeutics, they haven’t said how yet.
This website is for attendees of the event. I recommend a look at the “call for expression of interest page” to give an outline.
The webinar on the main page is good and shares views from healthcare workers and pharma about the current issues with covid therapeutics. They call for data from international platform trial using active comparator not placebo (good job with have Activ2).
Finally there is a focus on variants and the newly formed variant group are advising on selection of the next 5 drugs on the list to support. I think SNG has a great shot of being in the list of 10. The timing of the variant testing could explain this.
Hope that helps.
Ox.
HelloI hope you are all well? I wanted to share something I found today about EU covid therapeutics strategy. They are holding a manufacturing matchmaking event to introduce developers to manufacturers and healthcare purchasers, facilitated by the EU. I have no evidence SNG are involved but they are on the long list and randomly published variant testing recently (works on variants is a focus area). This could be really helpful for SNG in establishing a strong EU supply chain and maybe some funding. The webinar is worth a watch (bit the technical one). They give views from health are professionals and pharma. Also read call for expression of interest. Have a great weekend Oxhttps://development-production-covid19.b2match.io/home
Morning all,
Just popped back to say Welldone to all the LTH’s. Great RNS. I particularly liked:
- the simplicity of giving it to breathless patients at any stage of disease. Simple for doctors.
- new finding that breathless indicates the patients that will progress to severe infection
- direct shout to India
- request for platform trial at home. Maybe the UK one? Or hopefully Activ2 p3 can be on just the breathless patients?
Great news. See you all at 9am webinar!
Ox.